Medicure Inc.
MCUJF
$1.89
$0.010.53%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.49% | 49.55% | 45.51% | 56.79% | 27.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.49% | 49.55% | 45.51% | 56.79% | 27.70% |
| Cost of Revenue | 27.39% | 72.95% | 169.27% | 126.58% | 44.52% |
| Gross Profit | -9.30% | 27.82% | -27.10% | -1.90% | 15.08% |
| SG&A Expenses | 13.21% | 6.90% | 82.17% | 5.45% | 4.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.09% | 39.77% | 109.99% | 48.60% | 15.98% |
| Operating Income | -88.58% | 42.18% | -1,792.38% | -12.12% | 38.16% |
| Income Before Tax | -84.53% | 37.54% | -867.54% | -295.55% | 34.96% |
| Income Tax Expenses | -17.66% | -75.47% | -59.04% | 1,335.14% | -47.89% |
| Earnings from Continuing Operations | -76.99% | 39.62% | -666.51% | -303.29% | 36.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -76.99% | 39.62% | -666.51% | -303.29% | 36.13% |
| EBIT | -88.58% | 42.18% | -1,792.38% | -12.12% | 38.16% |
| EBITDA | -1,253.64% | 2,282.14% | -2,121.77% | -25.73% | 89.86% |
| EPS Basic | -77.02% | 39.52% | -665.44% | -303.14% | 36.15% |
| Normalized Basic EPS | -84.44% | 37.59% | -2,557.35% | -11.54% | 34.92% |
| EPS Diluted | -70.59% | 40.98% | -665.44% | -303.14% | 34.09% |
| Normalized Diluted EPS | -84.44% | 37.13% | -2,557.35% | -11.54% | 34.92% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | -0.57% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |